G01N 33/573
For enzymes or isoenzymes
Official title: for enzymes or isoenzymes
G01N33/573 (For enzymes or isoenzymes) appears on 2,454 US grants and 3,661 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,454
- Published applications
- 3,661
- Assignees
- 1,729
- Inventors
- 8,024
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 7 | 0 |
| 1987 | 7 | 0 |
| 1988 | 5 | 0 |
| 1989 | 11 | 0 |
| 1990 | 14 | 0 |
| 1991 | 13 | 0 |
| 1992 | 22 | 0 |
| 1993 | 29 | 0 |
| 1994 | 33 | 0 |
| 1995 | 25 | 0 |
| 1996 | 26 | 0 |
| 1997 | 41 | 0 |
| 1998 | 65 | 0 |
| 1999 | 67 | 0 |
| 2000 | 54 | 0 |
| 2001 | 86 | 12 |
| 2002 | 53 | 116 |
| 2003 | 53 | 157 |
| 2004 | 49 | 121 |
| 2005 | 53 | 121 |
| 2006 | 69 | 148 |
| 2007 | 52 | 130 |
| 2008 | 61 | 106 |
| 2009 | 53 | 140 |
| 2010 | 74 | 138 |
| 2011 | 62 | 138 |
| 2012 | 53 | 127 |
| 2013 | 81 | 143 |
| 2014 | 107 | 234 |
| 2015 | 125 | 265 |
| 2016 | 114 | 228 |
| 2017 | 132 | 171 |
| 2018 | 105 | 134 |
| 2019 | 121 | 150 |
| 2020 | 111 | 140 |
| 2021 | 80 | 132 |
| 2022 | 80 | 124 |
| 2023 | 63 | 114 |
| 2024 | 52 | 135 |
| 2025 | 68 | 135 |
| 2026 | 51 | 102 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Modulating human Cas9-specific host immune response29 Sep 2026US 12,747,432 B2Arizona Board of Regents on behalf of Arizona State University
- Diagnosis, prognosis and treatment of malignant neoplasms29 Sep 2026US 12,748,114 B2Rhode Island Hospital
- Kits22 Sep 2026US 12,742,779 B1Takeda Pharmaceutical Company Limited
- Extraction process of pancrelipase and evaluation thereof18 Aug 2026US 12,710,424 B2Kashiv Biosciences, LLC
- Anti-severe acute respiratory syndrome coronavirus antibodies11 Aug 2026US 12,704,517 B2Bio-Techne Corporation
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
- Compositions and methods for the treatment of disorders related to cdkl5 deficiency1 Oct 2026US 2026/0295084 A1Voyager Therapeutics, Inc.
- Risankizumab compositions1 Oct 2026US 2026/0297178 A1AbbVie Inc.
- Detection of molecular associations1 Oct 2026US 2026/0298929 A1California Institute of Technology
- Risankizumab compositions24 Sep 2026US 2026/0285967 A1AbbVie Inc.
Most cited
By later US patents
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016
- Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants639US 8,460,891 B2Dow AgroSciences LLC · 2013
- Technique for extracorporeal treatment of blood460US 5,910,252 ACobe Laboratories, Inc. · 1999
- Computer assisted methods for diagnosing diseases342US 5,769,074 AHorus Therapeutics, Inc. · 1998
- DNA sequences encoding coleoptera luciferase activity233US 5,674,713 AThe Regents of the University of California · 1997